1st Quarter - Report

LINCOLN POLICY GROUP for PFIZER

Firm
Client
Income
$80,000
Expenses
—

What was lobbied

One issue area, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Issues related to drug pricing S.2543 - Prescription Drug Pricing Reduction Act of 2019 H.R.3 - Elijah E. Cummings Lower Drug Costs Now Act Outreach regarding Rare Disease and Part-D copay assistance report language in FY2021 Labor HHS Appropriations cycle Outreach regarding drug supply concerns. Outreach regarding vaccine co-pay language in CARES Act (H.R. 748/S. 3548--Coronavirus Aid, Relief, and Economic Security Act) Outreach on biosimilar shared savings.

LobbyistCovered position, as disclosed
DAN ELLING —
ROBERT HOLIFIELD New Staff Director, Senate Agriculture Committee; Staff Director, Senate Finance Subcmte on Int'l Trade; Deputy Chief of Staff, CFTC; Director of External Affairs, CFTC
HANNAH LAMBIOTTE SMITH New Legislative Correspondent, Sen. Blanche Lincoln; Legislative Assistant; Sen. Blanche Lincoln; Staff Director, Senate Finance Subcmte Trade
BLANCHE LINCOLN —
COLIN ROSKEY —
THOMAS A SCULLY —

Contacted: HOUSE OF REPRESENTATIVES; SENATE; Health & Human Services, Dept of (HHS); Centers For Medicare and Medicaid Services (CMS)

Bills named: S. 2543 (116th), S. 3548 (116th), H.R. 748 (116th), H.R. 3 (116th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.